MDEChem to Hold Annual Meeting and Give a Maxheal Update

MDEChem, Inc. (PINK SHEETS: MDKM) a research and
development company is pleased to announce that it will be holding its
Annual Meeting on May 20th at the Comfort Suites Hotel in Houston
(Richmond & Fountainview Drives) 713-787-0004.
   The meeting is open to all shareholders and is scheduled to start
at 9:00AM and end at 11:30AM.
   The Company intends to update shareholders as to the progress that
is being made with various aspects of the business including an update
on EnviroFuels L.P. sales, marketing and testing efforts.
   Director nominations and the election of Directors will take place
at this meeting.
   The Company is on track to commence the marketing of its Maxheal
product line in the United States. The Maxheal line of products has
been registered and marketed in Costa Rica for the past 5 years. 5
years is a benchmark requirement for OTC products in order to be
marketed in the United States. Maxheal is an anti-bacterial and wound
healing agent used in first aid occurrences. It has been marketed
through MDEChem's Costa Rican subsidiary, Med Quimica S.A. of San
Jose, Costa Rica. Clinical studies currently under way by Dr. Enrique
Feoli continue to yield support to the "proof of concept" on the
potential use of MDECHEM's active ingredient for asthma control,
sports medicine and for periodontal uses. This Maxheal can be found in
the main pharmacies of Costa Rica and some other niches. The Maxheal
has gained a favorable presence in the marketplace and a solid
reputation of being a high quality and very efficacious product.
   MDEChem is currently reworking on the Maxheal website. The
website: www.maxhealcr.com will be posted by June 10th, 2005. The site
will be in English and Spanish.
   MDEChem and its Directors appreciate the continued patience of its
shareholders during the time it has taken to market the results of its
Research & Development (R&D) efforts.

   NOTE: Safe Harbor Statements may contain "forward looking
statements" under the Private Securities Litigation Reform Act of
1995. This announcement may contain "forward looking" statements.
Although we believe that the statements contained herein are
reasonable, no assurance can be guaranteed as to their accuracy,
authenticity or prove correct. Always consult an Investment Advisor
prior to investing.